1
|
Pavlidis N, Peccatori FA, Eniu A, Rassy E, Aapro M, Cavalli F, Lordick F, Costa A. Changing the landscape of European School of Oncology-European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic. Future Oncol 2022; 18:2857-2864. [PMID: 35722882 PMCID: PMC9245562 DOI: 10.2217/fon-2021-1477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
Abstract
Aims: This study aimed to assess the participants' evaluation of the European School of Oncology–European Society for Medical Oncology virtual masterclasses in clinical oncology (MCOs) organized during the pandemic in 2021. Materials & methods: The participants answered an online evaluation questionnaire at the end of each MCO to evaluate the content and organization of the MCO. Results: The clinical session and case presentation scores ranged between 4.6 and 4.8 over 5. The participants strongly agreed that the MCOs offered updates to improve their knowledge and practice in 68–83% and 52–76%, respectively; 74–90% of the participants considered the quality of the meetings to be excellent. Conclusion: The participants were satisfied with the virtual MCOs during the COVID-19 pandemic. Virtual MCO may be an acceptable alternative educational modality in specific circumstances. In 2002, the European School of Oncology (ESO) established masterclasses in clinical oncology (MCOs) and provided 41 in-person courses over the past two decades. As the COVID-19 pandemic forced travel restrictions and social distancing, the ESO and the European Society for Medical Oncology (ESMO) adapted the traditional MCOs to create virtual MCOs presented on e-ESO, an ESO e-learning platform. To date, five virtual MCOs have been organized for oncologists from western Europe, Latin America, Arab countries and southern Europe, the Baltic and Eurasia, eastern Europe and the Balkans. This study aimed to assess the participants' evaluation of the ESO-ESMO virtual MCOs organized during the pandemic in 2021 and to compare the participants' evaluation with that of previous in-person MCOs conducted between 2002 and 2019.
Collapse
Affiliation(s)
- Nicholas Pavlidis
- University of Ioannina, Ioannina, Greece.,European School of Oncology College (ESCO), Milan, 20121, Italy
| | - Fedro A Peccatori
- European School of Oncology (ESO), Milan, 20121, Italy.,Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, 20141, Italy
| | - Alexandru Eniu
- European School of Oncology College (ESCO), Milan, 20121, Italy.,Hospital Riviera Chablais, Rennaz, 1847, Switzerland
| | - Elie Rassy
- Gustave Roussy, Département de Médecine Oncologique, Villejuif, 94805, France
| | - Matti Aapro
- Breast Center, Genolier Cancer Centre, Genolier, 1272, Switzerland
| | - Franco Cavalli
- Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland
| | - Florian Lordick
- University of Leipzig Medical Centre, University Cancer Center (UCCL), Leipzig, 04103, Germany
| | - Alberto Costa
- European School of Oncology (ESO), Milan, 20121, Italy
| |
Collapse
|